First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin... von Patnaik, A., Appleman, L.J., Tolcher, A.W., Papadopoulos, K.P., Beeram, M., Rasco, D.W., Weiss, G.J., Sachdev, J.C., Chadha, M., Fulk, M., Ejadi, S., Mountz, J.M., Lotze, M.T., Toledo, F.G.S., Chu, E., Jeffers, M., Peña, C., Xia, C., Reif, S., Genvresse, I., Ramanathan, R.K.

Volltext

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours von Papadopoulos, K P, El-Rayes, B F, Tolcher, A W, Patnaik, A, Rasco, D W, Harvey, R D, LoRusso, P M, Sachdev, J C, Abbadessa, G, Savage, R E, Hall, T, Schwartz, B, Wang, Y, Kazakin, J, Shaib, W L

Volltext

Phase 1 dose-escalation study of the folic acid-tubulysin small-molecule drug conjugate (SMDC) folate-tubulysin EC1456: Study update von Sachdev, J.C., Edelman, M., Harb, W., Armour, A., Wang, D., Starodub, A.N.

Volltext

1198PFPA150 (B7-H4 antibody) phase I update in advanced solid tumours: Monotherapy and in combination with pembrolizumab von Wainberg, Z A, Sachdev, J C, Bauer, T, Pant, S, Chawla, S, Marina, N, Xiang, H, Deng, W, Schmidt, M, Patnaik, A, LoRusso, P

Volltext

A phase 1 study of PF-06647020, an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients with advanced solid tumors including platinum resistant ova... von Sachdev, J.C., Maitland, M., Sharma, M., Moreno, V., Boni, V., Kummar, S., Gibson, B., Xuan, D., Joh, T., Powell, E., Jackson-Fisher, A., Damelin, M., Xin, X., Tolcher, A., Calvo, E.

Volltext

Anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody imalumab (BAX69) in advanced solid tumors: Final results of first-in-human phase 1 study von Mahalingam, D., Patel, M.R., Sachdev, J.C., Hart, L.L., Halama, N., Ramanathan, R.K., Sarantopoulos, J., Liu, X., Yazji, S., Jäger, D., Yoon, M., Manzur, G.Ç, Adib, D., Kerschbaumer, R., Tsimberidou, A.

Volltext

Effect of race and comorbidities on patterns of bevacizumab toxicity: A single-institution experience von Raza, M., Raza, S., Latif, Z., Sachdev, J. C.

Volltext

Quantitative nuclease protection assay (qNPA) for gene expression analysis on breast cancer core biopsies von Evangelist, M. C., Krushkal, J., Qu, Y., Kulkarni, A., Kerns, B., Seligmann, B., Sachdev, J. C.

Volltext

Quantitative nuclease protection assay (qNPA) for gene expression analysis on breast cancer core biopsies von Evangelist, M. C., Snider, J., Krushkal, J., Qu, Y., Kulkarni, A., Kerns, B., Seligmann, B., Sachdev, J. C.

Volltext

Neoadjuvant bevacizumab with weekly nanoparticle albumin bound nab-paclitaxel plus carboplatin followed by doxorubicin plus cyclophosphamide (AC) for triple-negative breast cancer von Sachdev, J. C., Kronish, L. E., West, S., Schwartzberg, L., Jahanzeb, M.

Volltext

Surgical lymph node clearance and pathologic evaluation in gastric cancer von Khattak, A. G., Sachdev, J. C., Evangelist, M. C., Denbo, J., Orr, W. S., Ul-Haq, M., Farooq, A., Thompson, A. C., Dilawari, R. A., Osarogiagbon, R. U.

Volltext

A comparison of surgical resection for distal esophageal, gastroesophageal junction, and proximal gastric cancers in the Memphis metropolitan area (MMA) von Evangelist, M. C., Orr, W. S., Ul-Haq, M., Farooq, A., Khattak, A., Denbo, J., Mahmoud, A., Dilawari, R. A., Sachdev, J. C., Osarogiagbon, R. U.

Volltext

Does race affect outcomes in triple negative breast cancer (TNBC)? von Ahmed, S., Mirza, M. M., Farooq, A., Kronish, L., Jahanzeb, M., Sachdev, J. C.

Volltext

Maruyama index (MI) and outcomes of gastric cancer resection von Sachdev, J. C., Evangelist, M., Orr, W. S., Denbo, J., Khattak, A. G., Ul-Haq, M., Farooq, A., Thompson, A. C., Mahmoud, A., Osarogiagbon, R. U.

Volltext

Pattern of gastric cancer resection in the Memphis metropolitan area (MMA) von Evangelist, M., Sachdev, J. C., Khattak, A. G., Denbo, J., Orr, W. S., Ul-Haq, M., Berry, A., O'Brien, T., Dilawari, R. A., Osarogiagbon, R. U.

Volltext

Abstract OT3-02-14: A phase 1 study in patients with metastatic breast cancer to evaluate the feasibility of magnetic resonance imaging with ferrumoxytol as a potential biomarker f... von Sachdev, JC, Ramanathan, RK, Raghunand, N, Anders, C, Munster, P, Minton, S, Northfelt, D, Blanchette, S, Campbell, K, Lee, H, Klinz, SG, Hendriks, BS, Moyo, V, Fitzgerald, JB, Korn, RL

Volltext

Abstract OT3-3-07: Neoadjuvant bevacizumab with weekly nanoparticle albumin bound (nab)-paclitaxel plus carboplatin followed by doxorubicin plus cyclophosphamide (AC) for triple ne... von Snider, JN, Allen, JW, Young, R, Schwartzberg, L, Javed, Y, Jahanzeb, M, Sachdev, JC

Volltext

Abstract P2-09-02: BMN 673 is a PARP inhibitor in clinical development for the treatment of breast cancer patients with deleterious germline BRCA 1 and 2 mutations von Mina, LA, Ramanathan, RK, Wainberg, ZA, Byers, LA, Chugh, R, Sachdev, JC, Matei, D, Zhang, C, Henshaw, JW, Dorr, A, Kaye, SB, de Bono, JS

Volltext

Abstract P3-13-07: Clinicopathologic and Biologic Recurrence Risk in African-American Versus Caucasian Women with Early-Stage Hormone Receptor Positive Breast Cancer, a Single Inst... von Allen, AD, Allen, JW, Sachdev, JC

Volltext

Antifatty Liver Action of Proteolytic Enzymes of Animal and Plant Origin in Pancreatic Duct-Ligated Rats von Sachdev, J.C.

Volltext